vs

Side-by-side financial comparison of Adaptive Biotechnologies Corp (ADPT) and INDEPENDENT BANK CORP (IBCP). Click either name above to swap in a different company.

Adaptive Biotechnologies Corp is the larger business by last-quarter revenue ($70.9M vs $58.9M, roughly 1.2× INDEPENDENT BANK CORP). INDEPENDENT BANK CORP runs the higher net margin — 28.6% vs 4.7%, a 23.9% gap on every dollar of revenue. Over the past eight quarters, Adaptive Biotechnologies Corp's revenue compounded faster (28.1% CAGR vs 2.1%).

ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.

Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.

ADPT vs IBCP — Head-to-Head

Bigger by revenue
ADPT
ADPT
1.2× larger
ADPT
$70.9M
$58.9M
IBCP
Higher net margin
IBCP
IBCP
23.9% more per $
IBCP
28.6%
4.7%
ADPT
Faster 2-yr revenue CAGR
ADPT
ADPT
Annualised
ADPT
28.1%
2.1%
IBCP

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ADPT
ADPT
IBCP
IBCP
Revenue
$70.9M
$58.9M
Net Profit
$3.4M
$16.9M
Gross Margin
73.6%
Operating Margin
-27.1%
Net Margin
4.7%
28.6%
Revenue YoY
35.1%
Net Profit YoY
8.2%
EPS (diluted)
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADPT
ADPT
IBCP
IBCP
Q1 26
$70.9M
$58.9M
Q4 25
$71.7M
$58.3M
Q3 25
$94.0M
$57.3M
Q2 25
$58.9M
$55.9M
Q1 25
$52.4M
$54.1M
Q4 24
$47.5M
$62.0M
Q3 24
$46.4M
$51.4M
Q2 24
$43.2M
$56.5M
Net Profit
ADPT
ADPT
IBCP
IBCP
Q1 26
$3.4M
$16.9M
Q4 25
$-13.6M
$18.6M
Q3 25
$9.5M
$17.5M
Q2 25
$-25.6M
$16.9M
Q1 25
$-29.9M
$15.6M
Q4 24
$-33.7M
$18.5M
Q3 24
$-32.1M
$13.8M
Q2 24
$-46.2M
$18.5M
Gross Margin
ADPT
ADPT
IBCP
IBCP
Q1 26
73.6%
Q4 25
74.6%
Q3 25
80.7%
Q2 25
69.4%
Q1 25
67.6%
Q4 24
62.0%
Q3 24
64.1%
Q2 24
55.3%
Operating Margin
ADPT
ADPT
IBCP
IBCP
Q1 26
-27.1%
Q4 25
-17.8%
34.8%
Q3 25
10.9%
37.0%
Q2 25
-42.5%
37.0%
Q1 25
-56.4%
35.3%
Q4 24
-71.3%
36.7%
Q3 24
-70.3%
33.7%
Q2 24
-109.6%
41.0%
Net Margin
ADPT
ADPT
IBCP
IBCP
Q1 26
4.7%
28.6%
Q4 25
-18.9%
31.8%
Q3 25
10.2%
30.5%
Q2 25
-43.5%
30.2%
Q1 25
-56.9%
28.8%
Q4 24
-71.0%
29.8%
Q3 24
-69.1%
26.9%
Q2 24
-107.0%
32.8%
EPS (diluted)
ADPT
ADPT
IBCP
IBCP
Q1 26
$0.81
Q4 25
$-0.08
$0.88
Q3 25
$0.06
$0.84
Q2 25
$-0.17
$0.81
Q1 25
$-0.20
$0.74
Q4 24
$-0.22
$0.87
Q3 24
$-0.22
$0.65
Q2 24
$-0.31
$0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADPT
ADPT
IBCP
IBCP
Cash + ST InvestmentsLiquidity on hand
$77.6M
$174.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$510.6M
Total Assets
$505.9M
$5.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADPT
ADPT
IBCP
IBCP
Q1 26
$77.6M
$174.9M
Q4 25
$70.5M
$138.4M
Q3 25
$55.0M
$208.7M
Q2 25
$43.2M
$146.2M
Q1 25
$50.6M
$128.1M
Q4 24
$47.9M
$119.9M
Q3 24
$38.1M
$121.6M
Q2 24
$59.8M
$214.3M
Stockholders' Equity
ADPT
ADPT
IBCP
IBCP
Q1 26
$510.6M
Q4 25
$218.8M
$503.0M
Q3 25
$204.4M
$490.7M
Q2 25
$179.7M
$469.3M
Q1 25
$190.4M
$467.3M
Q4 24
$202.7M
$454.7M
Q3 24
$223.8M
$452.4M
Q2 24
$241.6M
$430.5M
Total Assets
ADPT
ADPT
IBCP
IBCP
Q1 26
$505.9M
$5.6B
Q4 25
$512.7M
$5.5B
Q3 25
$490.6M
$5.5B
Q2 25
$496.6M
$5.4B
Q1 25
$510.9M
$5.3B
Q4 24
$539.4M
$5.3B
Q3 24
$558.5M
$5.3B
Q2 24
$584.9M
$5.3B

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADPT
ADPT

Segment breakdown not available.

IBCP
IBCP

Net Interest Income$46.9M80%
Noninterest Income$12.0M20%

Related Comparisons